Admission Date:  [**2171-11-13**]              Discharge Date:   [**2171-11-15**]  Date of Birth:  [**2098-3-27**]             Sex:   F  Service: MEDICINE  Allergies: Morphine / Betalactams / Iodine-Iodine Containing / Meropenem  Attending:[**First Name3 (LF) 4611**] Chief Complaint: dizziness, hypoglycemia  Major Surgical or Invasive Procedure: None   History of Present Illness: 73F w/PMHx CLL and ITP, DM tx from [**Hospital 4199**] hospital due to persistent weakness and dizziness x 2d.
Pt reports that she has continued to have dull left sided abdominal pain; pt has had a distended abdomen due to established adenopathy, and states that there has been no change in abdominal girth.
She was given Calcium Gluconate 2g IV for K 7.4 (5.4 at [**Last Name (un) 4199**] previously) and Kayexylate 30g PO x1.
Denies nausea, vomiting, diarrhea, constipation, abdominal pain, melena, hematemesis, hematochezia.
Past Medical History: PAST ONCOLOGIC HISTORY: On [**2164-1-24**], received fludarabine and rituximab.
She went on to receive 2 cycles of fludarabine and then received Rituxan alone with four weeks of consolidation.
From [**2164-10-10**] to [**2164-11-2**], she received weekly Rituxan for thrombocytopenia that was refractory to steroids and IVIG.
From [**2166-2-24**] until [**2166-4-3**], she was treated with chlorambucil for painful adenopathy and IVC compression.
Her chlorambucil therapy was interrupted due to thrombocytopenia.
Ultimately chlorambucil was stopped on [**2166-10-2**].
Hospitalization from [**2167-1-8**] to [**2167-2-2**] because of airway compromise from her lymphadenopathy that required intubation and radiation therapy.
On [**2169-1-18**], she began cyclophosphamide for progression of her CLL in the form of a rising white blood cell count as well as Coombs positive hemolytic anemia and probable autoimmune thrombocytopenia.
Rituximab was held from the 1st cycle, but she then went on to receive 5 cycles of RCD (rituximab, cyclophosphamide, and dexamethasone).
She was subsequently started on rituximab and dexamethasone on [**2169-12-20**], as well as on [**2169-12-21**].
On [**2169-12-26**], she began pentostatin and rituximab with the pentostatin given at a dose of 2 mg/m2 once every three weeks.
She received 2 cycles of this chemotherapy with Neulasta support.
She received cycle 1 of bendamustine on [**2170-2-7**] and [**2170-2-8**] at a dose of 50 mg/m2 for relapsed CLL with bulky disease.
The bendamustine was dose reduced by 50% considering her renal function and tendency for cytopenias.
[**2170-3-20**] - [**2170-3-28**]: hospitalized for neutropenic fever, right foot swelling and treated for right leg/foot cellulitis and gout.
[**2170-6-13**]: Cycle 2 Bendamustine 50 mg/m2 (dose reduced)/Rituximab 375 mg/m2  [**2170-7-18**]: Cycle 3 Bendamustine 50 mg/m2/Rituximab 375 mg/m2  [**2170-8-22**]: Cycle 4 dose reduced [**Last Name (un) 106229**] 50 mg/m2/Rituxan 375 mg/m2.
[**8-15**] - [**2171-8-18**] R upper maxillary dental infection, right maxillary sinusitis treated with Clindamycin and tooth extractions .
PAST MEDICAL HISTORY: - Chronic ITP - CAD s/p stent to mid-proximal LAD in [**2163**] - Diastolic dysfunction, last EF 65%, [**7-/2169**] - h/o hypertensive cardiomyopathy, now resolved - AF - CKD [**2-14**] hypertensive nephrosclerosis, baseline Cr 1.8 - DM, Type II - GERD - Gout - Hypothyroidism - Hypertension - Dyslipidemia - Secondary hyperparathyroidism  Social History: Living in [**Location (un) 3146**] for the past 6 months with her husband.
ABD: Soft, NT, ND, bowel sounds present MSK: normal muscle tone and bulk EXT: No c/c, normal perfusion SKIN: No rash, warm skin NEURO: oriented x 3, normal attention, no focal deficits, intact sensation to light touch PSYCH: appropriate  DISCHARGE Vitals: T98.5 HR 68 BP 151/93 (120s150s/40s-90s) RR20 O2 sat 98% RA General: Alert, orientedx3, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: supple, JVP not elevated, scattered cervical LAD (tender in L anterior cervical chain/superclavicular matted lymphadenopathy CV: Regular rate and rhythm, normal S1 + S2, 2/6 systolic murmur in the LUSB, no rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: soft, mild tenderness to the left side abdomen, distended, bowel sounds present GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, 5/5 strength upper/lower extremities, grossly normal sensation, gait deferred; no vertiginous symptoms with head turning.
Was treated for her electrolyte abnormalities and was D/C on her diabetes medications and lisinopril with outpatient followup.
ACTIVE ISSUES # Diabetes Mellitus type 2, with Hyperglycemia after 2 days of hypoglycemia at outside hospital from probable Sulfonurea overdose - Patient was treated with insulin initially and her blood sugars stabilized.
Pioglitazone and Glipizide were stopped and she was diet controleld.
Advised her to followup with PCP before restarting any of her DM medications.
Patient received regular insulin 10 unit IVx1 and 10 units SC x1, calcium gluconate 1 g x 2, dextrose 50% x 1, and Kayexalate 60 g. Potassium levels normalized upon correction of glucose levels.
Lisinopril was discontinued pending PCP [**Name Initial (PRE) 4939**].
Lisinopril was held at time of discharge (as above)  # Chronic ITP: Platelets at baseline of high 20s, low 30s.
Held lisinopril for hyperkalemia.
# Hyperlipidemia: Continued home simvastatin .
# HTN: Continued home amlodipine  # Hypothyroidism: continued home levothyroxine  # H/o gout: continued allopurinol  TRANSITIONAL ISSUES 1) Hypertension - Stopped Lisinopril due to hyperkalemia, and patient was hypertensive during this admission.
[**Month (only) 116**] need to uptitrate or adjust regimen if Lisinopril continues to be held.
Carvedilol was not an option due to PR interval prolongation as well as borderline bradycardia at times on telemetry.
Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing 2.
Allopurinol 100 mg PO DAILY 3.
Amlodipine 10 mg PO DAILY 4.
Bisacodyl 5 mg PO DAILY:PRN constipation 5.
Carvedilol 12.5 mg PO BID 6.
Docusate Sodium 100 mg PO BID 7.
Doxepin HCl 50 mg PO HS 8.
Fluoxetine 20 mg PO DAILY 9.
Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 11.
Levothyroxine Sodium 137 mcg PO DAILY 12.
Multivitamins 1 TAB PO DAILY 13.
Omeprazole 20 mg PO DAILY 14.
Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN pain 15.
Senna 2 TAB PO DAILY:PRN constipation 16.
Simvastatin 40 mg PO DAILY 17. traZODONE 50 mg PO HS:PRN insomnia 18.
GlipiZIDE XL 5 mg PO DAILY 19.
Lisinopril 30 mg PO DAILY 20.
Pioglitazone 15 mg PO DAILY 21.
Torsemide 10 mg PO DAILY   Discharge Medications: 1.
Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing 2.
Allopurinol 100 mg PO DAILY 3.
Amlodipine 10 mg PO DAILY 4.
Carvedilol 12.5 mg PO BID 5.
Docusate Sodium 100 mg PO BID 6.
Doxepin HCl 50 mg PO HS 7.
Fluoxetine 20 mg PO DAILY 8.
Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 9.
Levothyroxine Sodium 137 mcg PO DAILY 10.
Multivitamins 1 TAB PO DAILY 11.
Omeprazole 20 mg PO DAILY 12.
Senna 2 TAB PO DAILY:PRN constipation 13.
Torsemide 10 mg PO DAILY 14.
Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN pain 15. traZODONE 50 mg PO HS:PRN insomnia   Discharge Disposition: Home With Service  Facility: [**Hospital 119**] Homecare  Discharge Diagnosis: Primary: Hypoglycemia/Hyperglycemia, Hyperkalemia Secondary: Chronic Lymphocytic Leukemia   Discharge Condition: Mental Status: Clear and coherent.
We treated you with medications to correct these issues.
You should STOP your diabetes medications until you follow up with your doctor.
You should also STOP Lisinopril until you see Dr. [**Last Name (STitle) **], and have him decide whether you can restart it.
Please review the attached medication list for the full details of the medications you should take.
